ETON - Balance Sheet - Eton Pharmaceuticals, Inc.

Current Liabilities	19.9 M
Accounts Payable	4.17 M
Short-Term Debt	0
Other Current Liabilities	15.8 M
Non-Current Liabilities	31.7 M
Long-Term Debt	29.9 M
Other Non-Current Liabilities	1.83 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	14.9	21.4	16.3	14.4	21.3	12.1	26.7	13.2
Short Term Investments	0	0	0	0	0	0	0	0
Receivables	5.4	3.4	1.9	5.5	48 K	0.5	0	0
Inventory	15.2	0.9	0.6	0.6	1.2	0.4	0	0
Other Current Assets	5.5	1.1	1.3	6.4	4.2	3.2	0.8	0.1
Total Current Assets	41.0	26.8	20.0	23.6	24.7	15.0	27.5	13.3
PP&E	0.2	0.1	0.3	0.2	1.0	1.3	0.8	0.1
Intangible Assets	34.9	4.7	4.8	3.6	0.6	0.7	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0
Other Long Term Assets	12 K	12 K	12 K	21 K	40 K	61 K	52 K	32 K
Other Assets	0	0	0	0	0	0	0	0
Total Assets	76.1	31.7	25.0	27.5	26.3	17.1	28.3	13.4
LIABILITIES
Accounts Payable	4.2	1.8	1.8	1.8	2.3	0.6	1.4	0.5
Short Term Debt	0	5.4	1.0	1.4	0.3	0	0	0
Other Current Liabilities	15.8	9.0	3.7	1.4	1.2	1.4	0.6	0.3
Total Current Liabilities	19.9	16.2	6.5	4.6	3.8	2.0	2.0	0.8
Long Term Debt	29.9	22 K	5.5	5.3	6.9	4.6	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0
Other Liabilities	1.8	0	0	0	0	0	0	0.5
Total Liabilities	51.7	16.3	12.0	9.8	10.7	6.5	2.0	1.3
EQUITY
Common Stock	27 K	26 K	25 K	25 K	24 K	18 K	18 K	6 K
Retained Earnings	(107.9)	(104.1)	(103.1)	(94.1)	(92.2)	(64.2)	(45.9)	(8.6)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	0	(19.0)
Total Equity	24.4	15.5	13.1	17.6	15.7	10.6	26.3	12.1
Total Liabilities and Equity	76.1	31.7	25.0	27.5	26.3	17.1	28.3	13.4
SHARES OUTSTANDING
Common Shares Outstanding	25.9	25.6	25.1	25.2	21.0	17.8	6.4	17.5

Free